This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Dupont Nutrition Biosciences Aps, Universite Laval (Canada). Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Québec, CA (2022)
- Québec City, CA (2023)
Company Filing History:
2 out of 149 
2 out of 2 Years Active: 2022-2023
Title: Alexander Hynes: Innovator in Biotechnology
Introduction
Alexander Hynes is a notable inventor based in Québec, Canada. He has made significant contributions to the field of biotechnology, particularly in the area of gene editing and regulation. With a total of 2 patents, Hynes has been at the forefront of innovative research that has the potential to transform agricultural practices and biotechnology applications.
Latest Patents
Hynes' latest patents include "Anti-CRISPR polynucleotides and polypeptides and methods of use" and "Anti-CRISPR genes and proteins and methods of use." The first patent provides methods and compositions for utilizing anti-CRISPR (ACR) proteins in plants. This includes the modulation of Cas endonuclease activity, improvement of the frequency of homologous recombination, and control of Cas endonuclease activity during various cell cycles. It also addresses spatial and/or temporal regulation of Cas endonuclease activity in plants, usage in gene activation or repression, and reduction of off-target polynucleotide cleavage. The second patent relates to anti-CRISPR genes and proteins, detailing their uses in various biotechnology applications.
Career Highlights
Throughout his career, Hynes has worked with prominent organizations such as DuPont Nutrition Biosciences Aps and Université Laval in Canada. His work has focused on advancing the understanding and application of gene editing technologies, particularly in agricultural biotechnology.
Collaborations
Hynes has collaborated with notable colleagues in the field, including Christophe Fremaux and Philippe Horvath. These collaborations have further enhanced his research and contributions to biotechnology.
Conclusion
Alexander Hynes is a distinguished inventor whose work in biotechnology, particularly in anti-CRISPR technologies, has significant implications for the future of genetic engineering and agricultural practices. His innovative patents and collaborations reflect his commitment to advancing the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile